Elaine J. Heron

Director at Palvella Therapeutics · 1 reported transaction in 1 company · latest trade Feb 27, 2026

Their record

Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.

Typical move +5.6%, S&P 500 +11.2% over the same days.


Palvella TherapeuticsPVLA	Bought $300K · 2,400 shares	Feb 27, 2026	S&P 500 +12.6%thru Oct 29

Feb 27, 2026 · PVLA

$300K

S&P 500 +12.6%thru Oct 29

1 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.